Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

XERS US Equity

Xeris Biopharma Holdings, Inc.Health Care · Pharmaceutical Preparations · CIK 1867096 · FY ends Dec 31
$8.70
+0.10 (+1.16%)
USD · as of 2026-08-21 · marketstack
DateEventWhat happened / filerSource
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-3113GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-07-178-K 8.01Other eventssec.gov ↗
2026-07-178-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-06-308-K 7.01Regulation FD disclosuresec.gov ↗
2026-06-308-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-06-118-K 8.01Other eventssec.gov ↗
2026-06-118-K 3.02Unregistered sales of equity securitiessec.gov ↗
2026-06-058-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-078-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-218-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-03-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-03-028-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-268-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-3013G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-01-088-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-12-018-K 7.01Regulation FD disclosuresec.gov ↗
2025-11-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-11-06

Every row is a filed document, checked against its EDGAR index.